Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies

Purpose: To report two new cases and summarize one case of uveal melanoma following treatment of hematologic malignancies with Bruton's tyrosine kinase inhibitors. Observations: A 71-year-old male, with a history of Waldenstrom macroglobulinemia treated with an anti-CD20 antibody and BTKi, was...

Full description

Bibliographic Details

Published in:	American Journal of Ophthalmology Case Reports
Main Authors:	Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	Uveal melanoma Bruton's tyrosine kinase inhibitor Hematologic malignancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993625000982